Physician
Pathology
Dr. Ilka R. Warshawsky, MD
|
|
Give Review
Doctor Ilka R. Warshawsky, MD is an expert in the field of Pathology. She studied medicine at Washington University School of Medicine in St. Louis. Ilka Warshawsky is a published doctor. She published 33 publications, including: 'Glypican-3 is a binding protein on the HepG2 cell surface for tissue factor pathway inhibitor.'
Publications
- Locked nucleic acid probes for enhanced detection of FLT3 D835/I836, JAK2 V617F and NPM1 mutations.
- Failure of the Ipsogen MutaScreen kit to detect the JAK2 617V>F mutation in samples with additional rare exon 14 mutations: implications for clinical testing and repor...
- Prothrombin 20209C>T: 16 new cases, association with the 19911A>G polymorphism, and literature review.
- Cytoplasmic localization of phosphorylated STAT5 in human acute myeloid leukemia is inversely correlated with Flt3-ITD.
- Multiplex ligation-dependent probe amplification for rapid detection of proteolipid protein 1 gene duplications and deletions in affected males and carrier females wit...
- Creation of a large-scale genetic data bank for cardiovascular association studies.
- Primary progressive multiple sclerosis as a phenotype of a PLP1 gene mutation.
- Pathologic clonal cytotoxic T-cell responses: nonrandom nature of the T-cell-receptor restriction in large granular lymphocyte leukemia.
- Importance of metastatic site analysis in determining tumor lineage in a lung transplant recipient.
- Thyrotropin receptor/thyroglobulin messenger ribonucleic acid in peripheral blood and fine-needle aspiration cytology: diagnostic synergy for detecting thyroid cancer.
- Comparison of five methods for extraction of Legionella pneumophila from respiratory specimens.
- A rare mutation in the primer binding region of the amelogenin gene can interfere with gender identification.
- A comparison of multiplex and monoplex T-cell receptor gamma PCR.
- Primary adenocarcinoma in a donor lung: evaluation and surgical management.
- Detection of a novel point mutation of the prothrombin gene at position 20209.
- Effect of substrate size on immunoinhibition of amylase activity.
- Macromolecular chromogenic substrates for measuring proteinase activity.
- Glypican-3 is a binding protein on the HepG2 cell surface for tissue factor pathway inhibitor.
- Differential functions of triplicated repeats suggest two independent roles for the receptor-associated protein as a molecular chaperone.
- The 39-kDa protein regulates LRP activity in cultured endothelial and smooth muscle cells.
- The low density lipoprotein receptor-related protein can function independently from heparan sulfate proteoglycans in tissue factor pathway inhibitor endocytosis.
- 39-kD protein inhibits tissue-type plasminogen activator clearance in vivo.
- Cellular receptors for the plasminogen activators.
- LRP and the receptor-mediated endocytosis of plasminogen activators.
- The carboxy terminus of tissue factor pathway inhibitor is required for interacting with hepatoma cells in vitro and in vivo.
- Identification of domains on the 39-kDa protein that inhibit the binding of ligands to the low density lipoprotein receptor-related protein.
- Analysis of ligand binding to the alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein. Evidence that lipoprotein lipase and the carboxyl-te...
- Sites within the 39-kDa protein important for regulating ligand binding to the low-density lipoprotein receptor-related protein.
- Identification of domains on the 39-kDa protein that inhibit the binding of ligands to the low density lipoprotein receptor--related protein.
- The low density lipoprotein receptor-related protein mediates the cellular degradation of tissue factor pathway inhibitor.
- Binding analysis of amino-terminal and carboxyl-terminal regions of the 39-kDa protein to the low density lipoprotein receptor-related protein.
- Cloning and expression of a cytosolic megakaryocyte protein-tyrosine-phosphatase with sequence homology to retinaldehyde-binding protein and yeast SEC14p.
Schools
Washington Center School of Medicine
Hospital University Pa
National Institute Health
Doctors Specialties
- Molecular Genetic Pathology
- Pathology
Accepted Insurances
Education
-
University of Pennsylvania Health System -
Washington University School of Medicine in St. Louis
Hospital
-
Cleveland Clinic
Helpful Reviews
Similar Doctors
|
|
Dr. Felicitas D. Juguilon, MD |